Skip to main content

SYSTEMATIC REVIEW article

Front. Endocrinol., 16 December 2022
Sec. Clinical Diabetes
This article is part of the Research Topic Innovation in Diabetes Self‐Care Management and Interventions View all 14 articles

Diabetes health coach in individuals with type 2 diabetes: A systematic review and meta analysis of quadruple aim outcomes

Megan RaceyMegan Racey1Milos JovkovicMilos Jovkovic1Paige AllistonPaige Alliston1Muhammad Usman AliMuhammad Usman Ali2Diana Sherifali*Diana Sherifali1*
  • 1McMaster Evidence Review and Synthesis Team; and School of Nursing, Faculty of Health Sciences, McMaster University, Hamilton, Ontario, ON, Canada
  • 2McMaster Evidence Review and Synthesis Team; and Department of Clinical Epidemiology & Biostatistics, Faculty of Health Sciences, McMaster University, Hamilton, Ontario, ON, Canada

Background: As diabetes self-management necessitates life-long learning, behaviour change, support, and monitoring, health coaching is a promising intervention to assist individuals in more than just meeting glycemic goals and glycated hemoglobin (A1C) targets. Currently, studies of health coaching for type 2 diabetes (T2DM) are limited due to their emphasis on glycemic control. The goal of this systematic review and meta-analysis is to determine the effects of health coaching on adults with T2DM based on quadruple aim outcomes and to assess the implementation of these interventions.

Methods: We searched 6 databases for randomized controlled trials of health coaching interventions delivered by a health professional for adults with T2DM. Reviewers screened citations, extracted data, and assessed risk of bias and certainty of evidence (GRADE). We assessed statistical and methodological heterogeneity and performed a meta−analysis of studies.

Results: Nine studies were included in this review. Our meta-analysis showed a significant reduction of A1C [0.24 (95% CI, -0.38 to -0.09)] after exposure to diabetes health coaching, and small to trivial significant benefits for BMI, waist circumference, body weight, and depression/distress immediately post intervention based on moderate certainty of evidence. However, long term benefit of these clinical outcomes were not maintained at follow-up timepoints. There was a small significant benefit for systolic blood pressure which was maintained after the completion of health coaching exposure at follow-up, but there was no statistically significant benefit in other secondary outcomes such as diastolic blood pressure and lipid profile measures (e.g. triglycerides). Very few studies reported on other quadruple aim measures such as patient-reported outcomes, cost of care, and healthcare provider experience.

Conclusions: Our systematic review and meta-analysis shows that health coaching interventions can have short term impact beyond glucose control on cardiometabolic and mental health outcomes. Future studies should try to examine quadruple aim outcomes to better assess the benefit and impact of these interventions at longer time points and following termination of the coaching program.

Systematic Review Registration: https://www.crd.york.ac.uk/prospero, identifier (CRD42022347478).

1 Introduction

Diabetes is increasingly a major health issue worldwide (1), with 1 in 10 adults living with diabetes in 2021. The rise in global rates of diabetes prevalence has led to challenges in managing diabetes at the health systems and societal levels, costing 966 billion USD in health care expenditures (2). The day-to-day management of diabetes is centred around the individual and ideally supported by a multi-disciplinary team to facilitate a patient’s ability to manage one’s own diabetes care through ongoing self-management education and support (3). Self-management education and support are most effective when tailored according to: the individual’s ability for learning and readiness for change; the context of one’s cultural beliefs, health beliefs and preferences; socioeconomic barriers and other health challenges (3).

In recent years, health coaching has emerged as an effective intervention to support diabetes self-management. According to Wolever et al., health coaching may be described as: a) patient centred; b) includes patient determined goals; c) incorporates self-discovery and active learning processes; d) encourages accountability for behavioural goals; e) provides some education alongside coaching; f) a health professional who is trained in behaviour change, communication, and motivational interviewing skills (4). Health coaching may also be timely and relevant health related education, behaviour change promotion, and psychosocial support to enhance the well-being of individuals and facilitate the achievement of their health-related goals (5, 6).

Although previously marred by small pilot studies, underpowered trials, and high attrition, a growing body of quality evidence for type 2 diabetes (T2DM) suggests that individuals achieve better health outcomes with health coaching than traditional education and support programs (4, 79). A scan of the literature identified a few systematic reviews related to health coaching (9, 10). The first review in 2003 synthesized the effect of health coaching components; it reviewed 25 individual health coaching studies for individuals with chronic illnesses and found that while education and behaviour change are important, they are not sufficient (10). Therefore the need for coach interactions that move a patient to a stage of action were evident, as was the need to consider the emotional state of the patient (10). The second review, completed in 2010, examined the evidence for health coaching on lifestyle behaviours (9). The review included relevant studies published between 1998 and 2008, of which 15 studies included, and only 7 were randomized controlled trials (RCTs). Although the review was also not specific to diabetes health coaching, the review did note that there were significant improvements in lifestyle behaviours (diet, physical activity, weight management), as well as medication adherence. Methodological limitations were identified in the review for the 7 trials, such as small sample sizes and incomplete follow-up (9). More recently, Sherifali et al., completed a review of 8 diabetes health coaching trials and determined that coaching interventions led to an overall reduction of glycated hemoglobin (A1C) by 0.32 (95% CI, -0.50 to -0.15) (11). Exposure to diabetes health coaching for more than 6 months led to a 0.57% reduction in A1C levels (95% CI, -0.76 to -0.38), compared to exposure to a diabetes health coach for ≤6 months (−0.23%; 95% CI, -0.37 to -0.09) (11). Finally, in 2018, Pirbaglou and colleagues reviewed the literature to consider the impact of diabetes health coaching on A1C, as well as on quality of life and self-efficacy (12). Health coaching interventions were also successful in reducing A1C levels at all time points, with the largest magnitude of reduction between 4 to 9 months, but found inconsistent benefits on psychosocial findings (12).

As diabetes self-management necessitates life-long learning, behaviour change, support, and monitoring, health coaching is a promising intervention to assist individuals in more than just meeting glycemic goals and A1C targets. At present, despite the growing body of evidence, studies of health coaching for T2DM are limited due to their emphasis on glycemic control. Therefore, we will explore the literature to determine the impact of diabetes health coaching on patient-reported outcomes, clinical outcomes, provider satisfaction, and cost-effectiveness, specifically the quadruple aim goals (13). As an adaptation of a 2015 systematic review and based on the evolution of health coaching (11), the goal of this systematic review and meta-analysis is to determine the effects of health coaching on adults with type 2 diabetes based on quadruple aim outcomes and subsequently, to assess the implementation of these interventions, including describing the diabetes health coaching intervention and in what context.

2 Methods

This systematic review and meta-analysis followed the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines (14) from a registered protocol (PROSPERO-CRD42022347478). Our methods followed the Cochrane Handbook for Systematic Reviews of Interventions Version 6, 2019 (15).

2.1 Search strategy

The search terms, databases, and strategy were developed in consultation with a research librarian at McMaster University and informed by a previous systematic review (11) (Supplemental Material 1). We searched MEDLINE, Embase/Emcare, Cumulative Index of Nursing and Allied Health Literature (CINAHL), PsycINFO, Cochrane Database of Systematic Reviews (CDSR) and Cochrane Central Register of Controlled Trials (CENTRAL) from inception to December 2021. We manually searched reference lists of relevant reviews and included studies for citations that were not captured in our search. Results from the search were deduplicated, and citations were uploaded to a secure internet-based platform for screening (DistillerSR, Evidence Partners Inc., Ottawa, Canada).

2.2 Study selection and eligibility

To be included, studies had to be written in English, been published in a peer-reviewed journal, and meet the following criteria: 1) be a RCT (randomized at the patient-level); 2) report data on adults ≥18 years of age with T2DM; 3) be a health coaching intervention (beyond one-dimensional education programs) that was delivered, led, and/or implemented by a regulated healthcare professional, one who would routinely see patients with diabetes for care or management in a healthcare setting such as a clinician, nurse, or diabetes educator in primary care, community care, or hospital-based programs; and 4) include a control group which was defined as treatment as usual, standard care, or minimal contact that did not contain intervention components. There were no criteria for diagnosis of T2DM; however, studies with general adult populations or mixed populations but which have subgroup analysis for participants with T2DM were also considered. Without subgroup analysis, a mixed population must have at least 80% of participants with our targeted condition (T2DM) to be included in our review. Outcomes were not used for inclusion or exclusion of the studies. Studies were excluded if: 1) they reported data on participants younger than 18 years of age, who did not have type 2 diabetes or who were pregnant; 2) health coaching was not the primary intervention; and 3) they were not RCTs, used a quasi-randomization methodology, including cluster randomization, or were pilot or feasibility trials.

2.3 Data extraction and quality assessment

A team of researchers conducted the screening and data extraction (MR, MJ, PA, DS). A minimum of 2 reviewers were required to independently and in duplicate screen titles and abstracts of all potentially eligible studies. Articles marked for inclusion by either team member went on to full-text screening which was completed independently and in duplicate by 2 team members and required consensus for inclusion or exclusion. We developed, piloted, and deployed standardized forms for data extraction. For each study, one team member extracted study characteristics, risk of bias (RoB) assessment (using the Cochrane Collaboration RoB tool (16) for RCTs), template for intervention description and replication (TIDieR) checklist and guide (17), and outcome data using electronic forms housed in a web-based systematic review software program. Two team members independently verified all extracted data and disagreements were resolved through discussion and/or third party consultation. All outcomes as they relate to the Quadruple Aim framework were considered. This framework was developed to optimize health system performance and includes improved patient experience (patient-reported outcomes), better population health (clinical population health outcomes), lower costs (cost of care outcomes) and improved clinical experience (healthcare provider experience) (13). In cases where studies had multiple measures for the same outcome, we extracted the primary or direct measures before using secondary outcomes or subgroup analysis data. All extraction was independently verified by the statistician (MA). Conflicts were resolved by the lead researcher of this review (MR).

We independently evaluated the certainty of the body of evidence using the Grading of Recommendation, Assessment, Development and Evaluations (GRADE) method (18) with GRADEpro software (19). GRADE rates the certainty of a body of evidence as high, moderate, low, or very low and ratings are based on an assessment of 5 conditions: 1) methodological quality, 2) consistency across effect estimates/statistical heterogeneity, 3) directness of the body of evidence to the populations, interventions, comparators and/or outcomes of interest, 4) precision of results, and 5) indications of reporting bias.

2.4 Statistical analysis

All data analyses were planned a priori. A meta-analysis was used to combine the results across studies by outcome using the published data from included studies. For continuous outcomes, we used change from baseline to immediate post-treatment (means, standard deviations) and the longest follow-up data (means, standard deviations). We used a random effects multi-level meta-analytic approach to account for dependency between effect sizes (i.e., the correlation between effect sizes due to multiple measures or sub-measures of the same outcome within a study or comparison of multiple interventions to a single control group). In such cases, multiple measures and comparisons from the same study were nested within studies first and variance in observed effect sizes was decomposed into sampling variance, within study variance and between-study variance to account for intra-cluster (or intraclass) correlation in the true effects true effects (20, 21). For the pooling of patient-reported outcomes such as quality of life, depression and distress, the direction of effect was adjusted to ensure consistency of desirable outcome responses. The summary measures of effect were generated in the form of standardized mean differences (SMD) (22). The SMD is interpreted based on its magnitude according to Cohen d recommended thresholds (~0.2 = small effect, ~0.5 = medium effect, ~0.8 = large effect) (23). For studies where measure of variance was reported as confidence intervals, standard error, or p-values, we used Cochrane recommended methods to convert this data to standard deviation (24). The statistical heterogeneity I2 statistic was also estimated in the context of multi-level meta-analytical approach i.e., within-cluster heterogeneity (multiple comparisons from same study) and between-cluster heterogeneity (effect sizes across studies). Overall I2 for each summary effect size was estimated to represent the heterogeneity not attributable to sample error and is the sum of within-cluster and between-cluster heterogeneity. The Cochran’s Q (α=0.05) was employed to detect statistical heterogeneity and I² statistic to quantify the magnitude of statistical heterogeneity between studies where I² >50% represents moderate and I² >75% represents substantial heterogeneity across studies. The primary subgrouping in each analysis was based on length of follow-up i.e. immediate post-treatment and long-term follow up. All analyses were performed using R software (metafor (25) and dmetar (26) packages).

3 Results

Our search strategy yielded 3,612 citations after duplicates were removed. We assessed 137 full-text articles for eligibility and included 9 RCTs in this review (Figure 1) (2735). The studies were published from 2014 to 2021. We searched databases from inception and considered all studies based on the above inclusion/exclusion criteria as these criteria were updated from our similar, previous review (11) and warranted thorough screening of the literature. However, we excluded studies that were published before 2015 (one-year overlap with our previous review) which met our inclusion/exclusion criteria as they were already described in our previous review as included studies. Based on the updated inclusion/exclusion criteria of this review, some studies published before 2015 were included in this review as they were excluded in the previous review based mostly on the inclusion requirement of A1C as a reported outcome and this was no longer an exclusion criteria of this review. Likewise, some studies from our 2015 review which were described as pilot of feasibility studies were excluded in this update due to the increased rigor of our study design criteria. The PICO of this review was updated from the 2015 review to reflect the evolution of the health coaching literature and topic area.

FIGURE 1
www.frontiersin.org

Figure 1 PRISMA Flow chart.

A total sample of 2,498 adults with T2DM were included in this review with a mean age ranging from 51.0 to 66.6 years and percentage of women in the studies ranging from 10% to 78%. The mean A1C at baseline ranged from 5.5% to 9.9%. Studies were conducted across the globe in North America, Europe, and Australia, and intervention duration was between 3 months to 3 years, with most being 6 or 12 months in duration (n=7). A total of 5 studies measured outcomes beyond immediate post-treatment and 4 of these studies conducted follow-up measurements 6 months after intervention completion (2932) while 1 study completed measurements 12 months post-intervention (28). Adverse events were only reported by 2 studies (27, 34). Balducci et al., 2019 reported any elective surgeries and medical conditions that occurred outside of the intervention and hypoglycemic episodes, arrythmias, and musculoskeletal injuries or discomfort that occurred during intervention visits or sessions (27). Sherifali et al., 2021 reported on hospitalizations (for any reason), emergency department visits, and hypo- and hyper-glycemic episodes requiring hospitalizations (34). There were no statistically significant differences in proportion of participants with adverse events between the 2 groups. Study characteristics are shown in Table 1 and more fulsome details can be found in Supplemental Material 2.

TABLE 1
www.frontiersin.org

Table 1 Characteristics of Included Studies.

3.1 Diabetes coaching intervention characteristics

The objective or rationale for the health coaching interventions was either to directly affect glycemic control or to influence glycemic control and/or diabetes management through other self-care behaviours and reducing risk factors (Table 1). As per our inclusion criteria, all studies used healthcare professionals to deliver the health coaching intervention. For most studies (n=7), just one type of coach was used but in 2 studies (30, 33), a team of health professionals worked together for the delivery of different components of the intervention. Coaches across the studies included a certified diabetologist, nurses, psychologists, doctoral students, community health workers, pharmacists, social workers, certified diabetes nurse educators, and a dietitian (Supplemental Material 2).

Coaching interventions were deployed using various strategies (Supplemental Materials 2, 3). Telephone-only strategies were used by 6 studies (28, 30, 3235), while telephone and face-to-face was used in 1 study (29), and 2 studies used in-person or face-to-face strategies only (27, 31). All the studies were focused on individual or one-on-one interactions and only 1 study also included group components. Sessions and interactions with the coaches ranged from weekly, to bi-weekly, to as infrequent as one session every 4 to 6 weeks. The duration of these sessions also varied from as short as 15 minutes to as long as 90 minutes; however, most seemed to average around 30 minutes. Any in-person components of the health coaching interventions took place in outpatient healthcare settings such as clinics, centres, primary care offices, and doctors offices (Supplemental Material 3). One study did not provide any details about the location of the intervention beyond geographical area, but it was a telephone/virtual program (34). The fact that over 60% of the included studies consisted of telephone-only interactions means that many of the intervention components and exchanges between the coaches and participants occurred from wherever the participant was at that time.

We described the diabetes health coaching intervention using the TIDieR checklist (17); reporting on the 12 domains were inconsistent with limited reporting on implementation fidelity (planned vs. actual) (Figure 2). Almost all the included studies specifically mentioned tailoring and personalization of the intervention to the participants needs (n=8), which is likely reflective of the personal nature of health coaching (Figure 2). While Balducci et al., did consist of individual face-to-face sessions with the coach (27), there was no explicit mention of how these sessions were tailored to the participant. Three studies mentioned the modification of the intervention from what was originally planned. Balducci et al., created a two-step scaled intensity for physical activity to support behaviour change (27). Based on feedback and study measures, Karhula et al., adjusted the length coaching phone calls to be shorter in duration (35). Young et al., had an unexpected recall of equipment that resulted in the use of a different activity tracker (29). Moreover, very few studies assessed how well the intervention was delivered (Figure 2). Four studies outlined plans to assess intervention fidelity, consisting of quality control measurements, listening to recordings of participant-coach interactions, and auditing of sessions, but only 1 included this as an outcome in their paper. Odnoletkova et al., conducted interviews with healthcare providers to assess intervention implementation (28). It is important to note that this component of TIDieR goes beyond attendance and adherence of the intervention by participants.

FIGURE 2
www.frontiersin.org

Figure 2 Spider chart of the total reporting of TIDieR Tool Items.

Studies were also mapped to the proposed Sherifali Diabetes Coaching Model (36). This model is comprised of four components: (i) personal case management and monitoring, emphasizing process of care issues and system navigation related to diabetes; (ii) diabetes self-management education and support, highlighting the need for knowledge, skill acquisition, and problem solving related to day-today management; (iii) behaviour modification, goal setting and reinforcement, using motivational interviewing and theories to facilitate goal setting, attainment, and behaviour change; and (iv) general psychosocial support, leveraging active listening and empathy to provide support. The studies in our review all included intervention components related to self-management and education (n=9) and almost all the studies also addressed behaviour modification (n=8). Psychosocial support was included in 66% of the studies (n=6), while only one third of the studies addressed personal case management and monitoring.

3.2 Risk of bias and quality of included studies

The Cochrane RoB tool showed mixed quality of study methodology: 4 studies were low risk of bias (2730), 4 were unclear risk of bias (3134), and 1 was high risk of bias (35) mostly due to issues regarding blinding of participants, providers, and/or outcome assessment (Table 2).

TABLE 2
www.frontiersin.org

Table 2 Risk of bias.

The certainty of evidence, as assessed by GRADE, ranged from very low to moderate due to concerns regarding risk of bias (studies rated as unclear risk of bias), inconsistency (direction of effect is not consistent with substantial heterogeneity observed across studies), and imprecisions (inadequate sample size and imprecise effect estimates with confidence intervals the include no effect) (Supplemental Material 4).

3.3 Benefits of treatment

We extracted and categorized outcomes based on the Quadruple Aim framework (13) and were able to meta-analyze outcomes for patient-reported and clinical population health outcomes. For the remaining outcomes, there was insufficient data and number of studies for meta-analysis, therefore, these are described narratively.

3.3.1 Patient-reported outcomes

Patient-reported outcomes included satisfaction, diabetes empowerment, quality of life, and depression/distress. Only 1 study reported on satisfaction using the Diabetes Treatment Satisfaction Questionnaire (28) and 1 reported on empowerment with the Diabetes Empowerment Scale (29). Quality of life outcomes were reported by 4 studies post-intervention and 2 studies at long-term follow-up using a variety of standardized tools/questionnaires; however, there was no significant effects between intervention or control groups at either time point (Supplemental Material 5). Five studies reported the effect of the coaching intervention on depression/distress. At immediate post-treatment, health coaching interventions showed a significant decrease of small magnitude in depression/distress levels of 0.21 (95% CI, -0.41 to -0.02) based on moderate certainty of evidence (Figure 3; Supplemental Material 4). At long-term follow-up, the 4 studies with data did not show a significant effect.

FIGURE 3
www.frontiersin.org

Figure 3 The effect of coaching interventions on depression/distress.

3.3.2 Clinical population health

Glucose control was measured by glycosylated hemoglobin (A1C) and fasting blood glucose (FBG). Eight of the nine studies reported the effect of the coaching intervention on A1C levels. At immediate post-treatment, data from 7 health coaching interventions showed a significant decrease of small magnitude in A1C levels of 0.24 (95% CI, -0.38 to -0.09) based on moderate certainty of evidence (Figure 4; Supplemental Material 4). At long-term follow-up, the 4 studies with A1C data did not show a significant effect. FBG was reported in 2 studies (27, 32). Immediately post-treatment, both studies found significant improvements in FBG; however, this effect was not maintained at long-term follow-up in Varney et al.

FIGURE 4
www.frontiersin.org

Figure 4 The effect of coaching interventions Hba1c levels.

Studies also measured anthropometric outcomes including body mass index (BMI), waist circumference, and body weight. Two studies measured BMI post-intervention and 3 studies measured BMI at long-term follow-up. At immediate post-treatment, health coaching interventions showed a significant decrease of small magnitude in BMI of 0.19 (95% CI, -0.35 to -0.03) based on moderate certainty of evidence (Figure 5A; Supplemental Material 4); however, this effect was not maintained at long-term follow-up. Similarly, at immediate post-treatment, data from 3 health coaching interventions showed a significant decrease in waist circumference of small magnitude of 0.24 (95% CI -0.41 to -0.07) based on moderate certainty of evidence (Figure 5B; Supplemental Material 4); however, this effect was not maintained at long-term follow-up with data from 2 studies. Lastly, the data from 5 studies on body weight at post-intervention and 2 studies at long-term follow-up showed similar trends. At immediate post-treatment, health coaching interventions showed a significant decrease of small magnitude in body weight of 0.19 (95% CI -0.30 to -0.08) based on moderate certainty of evidence (Figure 5C; Supplemental Material 4). At long-term follow-up, the data did not show a significant effect.

FIGURE 5
www.frontiersin.org

Figure 5 The effort of coaching interventions on anthropometric outcomes ((A). BMI; (B) Waist circumtances; (C) Body Weight).

Blood pressure was reported as both systolic and diastolic in our included studies. At immediate post-treatment, data from 5 health coaching interventions showed a significant decrease of small magnitude in systolic blood pressure of 0.28 (95% CI -0.40 to -0.16) based on moderate certainty of evidence (Figure 6; Supplemental Material 4) and this effect was maintained at long-term follow-up based on data from 3 studies with a significant decrease of small magnitude of 0.38 (95% CI -0.53 to -0.23) based on moderate certainty of evidence (Figure 6; Supplemental Material 4). Diastolic blood pressure data came from 4 studies at post-treatment and 3 studies at long-term follow-up; however, health coaching interventions did not show significant effects at either time point (Supplemental Material 5).

FIGURE 6
www.frontiersin.org

Figure 6 The effect of coaching interventions on systolic blood pressure.

Lastly, many of our included studies measured other cardiometabolic outcomes from blood triglycerides and cholesterol levels. Data from 4 studies at immediate post-treatment and 3 studies at long-term follow-up showed no significant effects from the coaching interventions on total cholesterol, low density lipoprotein (LDL), high density lipoprotein (HDL), or triglycerides (Supplemental Material 5).

3.3.3 Cost of care

Outcomes related to cost of care were measured in 2 studies (28, 30) as the use of health care services. Both studies measured clinic visits including mental health clinic visits, primary care/general practitioner clinic visits, and other healthcare specialist visits such as endocrinologists, cardiologists, and ophthalmologists. Naik et al., did not see any significant differences in health care use or clinic visits between treatment and control groups, but Odnoletkova did find significant differences between treatment and control groups. Those randomized to the coaching intervention sought out healthcare services and specialist visits and tests more than those in the control group. There was no data from our included studies on the cost of care such as cost of the coaching interventions, or any cost savings due to the intervention programs.

3.3.4 Healthcare provider experience

Odnoletkova was the only study in our included articles to report on healthcare provider experience and this was described in a mixed-method study embedded in their clinical trial (37). Through both questionnaires and interviews, the study explored the perceptions of participants, nurses, and general practitioners (GPs) regarding the telecoaching intervention. Overall, both GPs and nurses found the coaching intervention to be sufficient and facilitated their work and noted that diabetes education is lacking in their training. According to most GPs, work still needs to be done to identify the groups of patients who would benefit from coaching programs using different methods (i.e. in person vs telephone). Healthcare providers agreed that a combination of phone and face-to-face consultations is necessary.

4 Discussion

We examined the literature to determine the impact of diabetes health coaching on the quadruple aim outcomes of patient-reported outcomes, clinical outcomes, provider satisfaction, and cost-effectiveness, and to describe the implementation and context of diabetes health coaching interventions. A total of 9 trials from Europe, Australia, and North America were included and the description of what comprised diabetes health coaching as an intervention was consistent across studies and previously published literature (11, 12). While 8 of the 9 studies reported on the impact of diabetes health coaching on glycemic control, there was limited evidence on patient-reported outcomes, provider satisfaction, and cost of care.

Similar to other reviews (11, 12, 38), our review of the literature found that diabetes health coaching interventions are still diverse with respect to the delivery personnel, mode of delivery, and most notably when it comes to the frequency, duration, and location of coaching interactions and sessions. The differences in the mode of delivery and length of interventions raises the need for further research into which study-level factors are most effective for all the quadruple aim outcomes. There was great variability in the individual components of the coaching interventions; however, they still aligned well to the Sherifali Coaching model (36) and definitions of health coaching more broadly (46). The reporting of intervention components also aligned with standard reporting guidelines such as CONSORT (39). The studies in our review provided details related to the why, what, who, how, where, and when of diabetes health coaching interventions, but components related to intervention fidelity were lacking.

Our meta-analysis showed a statistically and clinically significant reduction of A1C [0.24 (95% CI, -0.38 to -0.09)] after exposure to diabetes health coaching, and small to trivial benefits for BMI, waist circumference, body weight, and depression/distress at post treatment. However, long term benefit was not seen across all clinical outcomes, following the completion of the diabetes health coaching intervention. Although there was a small benefit noted for systolic blood pressure, which was maintained following diabetes health coaching exposure, there was no statistically significant benefit in other secondary outcomes such as diastolic blood pressure and lipid profile measures (e.g. triglycerides). It is important to note that there is heterogeneity and imprecision in the health coaching interventions and associated data from our included studies which downgrades our confidence in the generalizability of these treatment effects and lowers the overall certainty of evidence rating (GRADE) for specific outcomes. In such cases, these results and their generalizability should be interpreted with caution, warranting future high quality research with adequate sample sizes to further affirm the findings of our systematic review and meta-analysis.

The pooled treatment effect of diabetes health coaching on A1C is smaller in magnitude than previous reviews which have estimated approximately a 0.5% reduction in A1C following a six month diabetes health coaching intervention (11, 12). The decrease in pooled treatment effect size in our review may be due to the changing nature of diabetes self-management, with many diabetes clinical guidelines and standards of practice placing a greater emphasis on self-management support, particularly starting around 2015 (3). Furthermore, as the development, implementation, and evaluation of diabetes health coaching as an intervention gains greater attention, fewer pilot studies are being conducted. Pilot studies often yield larger and less precise effect sizes, whereas full-scale RCTS with powered sample sizes and larger trials are yielding more precise, real-world estimates of diabetes health coaching in a variety of contexts. However, longer duration intervention studies are required to fully assess the implementation, impact on clinical population health outcomes, cost of care, sustainability, and legacy effect of diabetes health coaching since other reviews also found a reduced effectiveness of these interventions with longer study durations beyond one year (12).

The examination of quadruple aim goals in the context of diabetes health coaching demonstrated a paucity of evidence. Specifically, clinical outcomes related to blood pressure and lipid management may require longer duration studies, beyond 6 months, to yield observed clinical benefits. Other reviews have also failed to find a significant benefit of health coaching interventions for these cardiometabolic clinical outcomes (38). Beyond these clinical outcomes, we also found there was limited evidence on patient-reported outcomes, provider satisfaction, and cost of care. The few studies that did report on these outcomes showed mixed results, and while we found a significant decrease of small magnitude in depression/distress levels of 0.21 (95% CI, -0.41 to -0.02), other reviews have not seen the same significance in their analyses (12, 38). One explanation for these findings may be the emphasis that diabetes health coaching interventions currently place on metabolic control of T2DM. The patient-reported outcomes may require more psychologically focussed programming. Based on the Sherifali Coaching model (36), we found psychosocial support was included in only 66% of the studies (n=6), while only one third of the studies addressed personal case management and monitoring.

Our review was comprehensive, having searched multiple databases and leveraged a comprehensive search strategy from a previous review. However, we did not search grey literature and we only included studies that met our predetermined inclusion criteria. We have noted that there is heterogeneity in our included studies but unfortunately, we could not perform any meta-regression analysis based on study-level factors (such as coaching intervention type, length of intervention, or population) as there were too few studies to conduct such analysis. We also applied a transparent definition of diabetes health coaching which may be excluding studies in which diabetes health coaching was delivered by a non-health care professional. However, by applying the TIDieR checklist to the descriptions of the study interventions, we are contributing to the greater understanding of what comprises diabetes health coaching.

5 Conclusions

Findings from this systematic review and meta-analysis showed that the diabetes health coaching literature continues to evolve, adding more evidence from larger trials of longer duration on the benefit on glucose control (such as A1C). Health coaching interventions can have short term impact beyond glucose control on cardiometabolic and mental health outcomes. As diabetes health coaching continues to be implemented as a self-management support intervention, future research should continue to explore the impact of health coaching on patient reported outcomes, other metabolic health outcomes, provider satisfaction, and cost to better assess the impact of these interventions at longer time points following the termination of the coaching program. More broadly, this systematic review provides a road map of gaps and opportunities for future research in diabetes health coaching evaluation and implementation.

Data availability statement

The original contributions presented in the study are included in the article/Supplementary Material. Further inquiries can be directed to the corresponding author.

Author contributions

All authors were involved in conception and design of the study and approved the protocol; MR, DS were responsible for overseeing the search of databases and literature. MR handled management of database and deduplication or records. MR, MJ, PA, DS were involved in the screening of citations; MR, MJ, PA were responsible for data extraction; MR, MA, DS were responsible for data verification and analysis of data. MR, MA, DS were involved in interpretation of data. All authors supported in the drafting of the manuscript which was led by MR and all authors supported in revising and formatting of the manuscript. All authors contributed to the article and approved the submitted version.

Funding

This research was funded by the McMaster Evidence Review and Synthesis Team (MERST). Diana Sherifali holds the Heather M Arthur Population Health Research Institute/Hamilton Health Sciences Chair in Interprofessional Health Research which supported her role in this work.

Acknowledgments

The authors thank Angela Eady for developing the search strategy and Saira Khalid for supporting in creation of tables and figures for the manuscript.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Supplementary material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fendo.2022.1069401/full#supplementary-material

References

1. Khan MAB, Hashim MJ, King JK, Govender RD, Mustafa H, Al Kaabi J. Epidemiology of type 2 diabetes - global burden of disease and forecasted trends. J Epidemiol Global Health (2020) 10((1):107–. doi: 10.2991/jegh.k.191028.001

CrossRef Full Text | Google Scholar

2. Diabetes around the world in 2021: IDF diabetes atlas (2021). Available at: https://diabetesatlas.org/.

Google Scholar

3. Sherifali D, Berard LD, Gucciardi E, MacDonald B, MacNeill G. Self-management education and support. Can J Diabetes. (2018) 42:S36–41. doi: 10.1016/j.jcjd.2017.10.006

PubMed Abstract | CrossRef Full Text | Google Scholar

4. Wolever RQ, Dreusicke M, Fikkan J, Hawkins TV, Yeung S, Wakefield J, et al. Integrative health coaching for patients with type 2 diabetes: a randomized clinical trial. Diabetes educator. (2010) 36(4):629–39. doi: 10.1177/0145721710371523

CrossRef Full Text | Google Scholar

5. Huffman M. Health coaching: A new and exciting technique to enhance patient self-management and improve outcomes. Home Healthcare Now. (2007) 25(4):271–4. doi: 10.1097/01.NHH.0000267287.84952.8f

CrossRef Full Text | Google Scholar

6. Wong-Rieger D. Health coaching for chronic conditions engaging and supporting patients to self-manage. Toronto, ON: Institute for Optimizing Health Outcomes (2011).

Google Scholar

7. Ruggiero L, Moadsiri A, Butler P, Oros SM, Berbaum ML, Whitman S, et al. Supporting diabetes self-care in underserved populations: a randomized pilot study using medical assistant coaches. Diabetes Educator. (2010) 36(1):127–31. doi: 10.1177/0145721709355487

CrossRef Full Text | Google Scholar

8. Whittemore R, Melkus GD, Sullivan A, Grey M. A nurse-coaching intervention for women with type 2 diabetes. Diabetes Educator. (2004) 30(5):795–804. doi: 10.1177/014572170403000515

CrossRef Full Text | Google Scholar

9. Webb TL, Joseph J, Yardley L, Michie S. Using the Internet to promote health behavior change: A systematic review and meta-analysis of the impact of theoretical basis, use of behavior change techniques, and mode of delivery on efficacy. J Med Internet Res (2010) 12(1):e4. doi: 10.2196/jmir.1376

PubMed Abstract | CrossRef Full Text | Google Scholar

10. Lindner H, Menzies D, Kelly J, Taylor S, Shearer M. Coaching for behaviour change in chronic disease: A review of the literature and the implications for coaching as a self-management intervention. Aust J Primary Health (2003) 9(3):177–85. doi: 10.1071/PY03044

CrossRef Full Text | Google Scholar

11. Sherifali D, Bai JW, Kenny M, Warren R, Ali MU. Diabetes self-management programmes in older adults: a systematic review and meta-analysis. Diabetic Med (2015) 32(11):1404–14. doi: 10.1111/dme.12780

PubMed Abstract | CrossRef Full Text | Google Scholar

12. Pirbaglou M, Katz J, Motamed M, Pludwinski S, Walker K, Ritvo P. Personal health coaching as a type 2 diabetes mellitus self-management strategy: A systematic review and meta-analysis of randomized controlled trials. Am J Health Promot (2018) 1(7):1613–26. doi: 10.1177/0890117118758234

CrossRef Full Text | Google Scholar

13. Bodenheimer T, Sinsky C. From triple to quadruple aim: Care of the patient requires care of the provider. Ann Family Med (2014) 12(6):573. doi: 10.1370/afm.1713

CrossRef Full Text | Google Scholar

14. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ (2009) 339:b2535. doi: 10.1136/bmj.b2535

PubMed Abstract | CrossRef Full Text | Google Scholar

15. Higgins JPT TJ, Chandler J, Cumpston M, Li T, Page MJ, Welch VA. Cochrane handbook for systematic reviews of interventions version 6.3. 2nd Edition. Chichester, UK: John Wiley & Sons (2022).

Google Scholar

16. Higgins JPT, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, et al. The cochrane collaboration’s tool for assessing risk of bias in randomised trials. BMJ (2011) 343:d5928. doi: 10.1136/bmj.d5928

PubMed Abstract | CrossRef Full Text | Google Scholar

17. Hoffmann TC, Glasziou PP, Boutron I, Milne R, Perera R, Moher D, et al. Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. BMJ Br Med J (2014) 348:g1687. doi: 10.1136/bmj.g1687

CrossRef Full Text | Google Scholar

18. Schünemann H BJ, Guyatt G, Oxman A. GRADE handbook for grading quality of evidence and strength of recommendations. The GRADE Working Group (2013). Available at: https://gdt.gradepro.org/app/handbook/handbook.html.

Google Scholar

19. GDT g. GRADEpro guideline development tool [Software]. McMaster University (2015).

Google Scholar

20. Pastor DA, Lazowski RA. On the multilevel nature of meta-analysis: A tutorial, comparison of software programs, and discussion of analytic choices. Multivariate Behav Res (2018) 53(1):74–89. doi: 10.1080/00273171.2017.1365684

PubMed Abstract | CrossRef Full Text | Google Scholar

21. Assink M, Wibbelink CJM. Fitting three-level meta-analytic models in r: A step-by-step tutorial. Quantitative Methods Psychol (2016) 12(3):154–74. doi: 10.20982/tqmp.12.3.p154

CrossRef Full Text | Google Scholar

22. DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clin Trials. (1986) 7(3):177–88. doi: 10.1016/0197-2456(86)90046-2

CrossRef Full Text | Google Scholar

23. Cohen J. Statistical power analysis for the behavioral sciences (2nd ed.). Hillsdale, NJ: Lawrence Erlbaum Associates, Publishers (1988).

Google Scholar

24. Higgins JPT LT, Deeks JJ. Choosing effect measures and computing estimates of effect. In: Higgins JPT LT, Deeks JJ, editors. Cochrane handbook for systematic reviews of interventions (2019). 143–76. Available at: https://training.cochrane.org/handbook/current/chapter-06.

Google Scholar

25. Viechtbauer W. Conducting meta-analyses in r with the metafor package. J Stat Software (2010) 36(3). doi: 10.18637/jss.v036.i03

CrossRef Full Text | Google Scholar

26. Harrer M CP, Furukawa T. Ebert DD dmetar: Companion r package for the guide 'Doing meta-analysis in r'. r package version 0.0.9000. (2019).

Google Scholar

27. Balducci S, D'Errico V, Haxhi J, Sacchetti M, Orlando G, Cardelli P, et al. Effect of a behavioral intervention strategy on sustained change in physical activity and sedentary behavior in patients with type 2 diabetes: The IDES_2 randomized clinical trial. JAMA: J Am Med Assoc (2019) 321(9):880–90. doi: 10.1001/jama.2019.0922

CrossRef Full Text | Google Scholar

28. Odnoletkova I, Goderis G, Nobels F, Fieuws S, Aertgeerts B, Annemans L, et al. Optimizing diabetes control in people with type 2 diabetes through nurse-led telecoaching. Diabetic Med (2016) 33(6):777–85. doi: 10.1111/dme.13092

PubMed Abstract | CrossRef Full Text | Google Scholar

29. Young HM, Miyamoto S, Dharmar M, Tang-Feldman Y. Nurse coaching and mobile health compared with usual care to improve diabetes self-efficacy for persons with type 2 diabetes: randomized controlled trial. JMIR mhealth uhealth. (2020) 8(3):e16665. doi: 10.2196/16665

PubMed Abstract | CrossRef Full Text | Google Scholar

30. Naik AD, Hundt NE, Vaughan EM, Petersen NJ, Zeno D, Kunik ME, et al. Effect of telephone-delivered collaborative goal setting and behavioral activation vs enhanced usual care for depression among adults with uncontrolled diabetes: a randomized clinical trial. JAMA network Open (2019) 2(8):e198634. doi: 10.1001/jamanetworkopen.2019.8634

PubMed Abstract | CrossRef Full Text | Google Scholar

31. Jutterström L, Hörnsten Å, Sandström H, Stenlund H, Isaksson U. Nurse-led patient-centered self-management support improves HbA1c in patients with type 2 diabetes-a randomized study. Patient Educ Counseling. (2016) 99(11):1821–9. doi: 10.1016/j.pec.2016.06.016

CrossRef Full Text | Google Scholar

32. Varney JE, Weiland TJ, Inder WJ, Jelinek GA. Effect of hospital-based telephone coaching on glycaemic control and adherence to management guidelines in type 2 diabetes, a randomised controlled trial. Internal Med J (2014) 44(9):890–7. doi: 10.1111/imj.12515

CrossRef Full Text | Google Scholar

33. Cummings DM, Lutes LD, Littlewood K, Solar C, Carraway M, Kirian K, et al. Randomized trial of a tailored cognitive behavioral intervention in type 2 diabetes with comorbid depressive and/or regimen-related distress symptoms: 12-month outcomes from COMRADE. Diabetes Care (2019) 42(5):841–8. doi: 10.2337/dc18-1841

PubMed Abstract | CrossRef Full Text | Google Scholar

34. Sherifali D, Brozic A, Agema P, Punthakee Z, McInnes N, O'Reilly D, et al. Effect of diabetes health coaching on glycemic control and quality of life in adults living with type 2 diabetes: a community-based, randomized, controlled trial. Can J Diabetes (2021) 45(7):594–600. doi: 10.1016/j.jcjd.2020.11.012

PubMed Abstract | CrossRef Full Text | Google Scholar

35. Karhula T, Vuorinen AL, Rääpysjärvi K, Pakanen M, Itkonen P, Tepponen M, et al. Telemonitoring and mobile phone-based health coaching among Finnish diabetic and heart disease patients: randomized controlled trial. J Med Internet Res (2015) 17(6):e153. doi: 10.2196/jmir.4059

PubMed Abstract | CrossRef Full Text | Google Scholar

36. Sherifali D. Diabetes coaching for individuals with type 2 diabetes: A state-of-the-science review and rationale for a coaching model. [Review] (2017) 1(6):547–54. doi: 10.1111/1753-0407.12528

CrossRef Full Text | Google Scholar

37. Odnoletkova I, Buysse H, Nobels F, Goderis G, Aertgeerts B, Annemans L, et al. Patient and provider acceptance of telecoaching in type 2 diabetes: a mixed-method study embedded in a randomised clinical trial. BMC Med Inf Decision Making. (2016) 16:142–. doi: 10.1186/s12911-016-0383-3

CrossRef Full Text | Google Scholar

38. Radwan NM, Al Khashan H, Alamri F, El Olemy AT. Effectiveness of health coaching on diabetic patients: A systematic review and meta-analysis. (Edinburgh, Scotland: WDEC 2020, 2nd World Congress on Diabetes and Endocrinology) (2019).

Google Scholar

39. Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ (2010) 340:c332. doi: 10.1136/bmj.c332

PubMed Abstract | CrossRef Full Text | Google Scholar

Keywords: health coaching, systematic reveiw, meta analysis, quadruple aim, type 2 diabetes

Citation: Racey M, Jovkovic M, Alliston P, Ali MU and Sherifali D (2022) Diabetes health coach in individuals with type 2 diabetes: A systematic review and meta analysis of quadruple aim outcomes. Front. Endocrinol. 13:1069401. doi: 10.3389/fendo.2022.1069401

Received: 13 October 2022; Accepted: 28 November 2022;
Published: 16 December 2022.

Edited by:

Hiroshi Okada, Matsushita Memorial Hospital, Japan

Reviewed by:

Hanako Nakajima, Kyoto Prefectural University of Medicine, Japan
Gillian Hood, Queen Mary University of London, United Kingdom

Copyright © 2022 Racey, Jovkovic, Alliston, Ali and Sherifali. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Diana Sherifali, dsherif@mcmaster.ca

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.